Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,011.30
+3.10 (0.15%)
At close: Jan 14, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 567.59 billion as of January 14, 2026. Its market cap has increased by 26.83% in one year.
Market Cap
567.59B
Enterprise Value
552.93B
Revenue
159.97B
Ranking
n/a
PE Ratio
56.21
Stock Price
2,011.30
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 567.59B, an increase of 49,285.62%. That is a compound annual growth rate of 28.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 567.59B | -1.17% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.17T |
| Apollo Hospitals Enterprise | 1.05T |
| Mankind Pharma | 918.20B |
| Zydus Lifesciences | 906.31B |
| Alkem Laboratories | 701.07B |
| Fortis Healthcare | 685.50B |